期刊文献+

索利那新治疗膀胱过度活动症患者逼尿肌功能的影响

暂未订购
导出
摘要 目的研究M3受体拮抗剂索利那新治疗膀胱过度活动症患者逼尿肌功能的影响。方法将本次研究纳入的110名膀胱过度活动症患者随机均分为临床组和参照组各55例。临床组患者服索利那新治疗。参照组服托特罗定治疗。8周为1疗程。而后比较两组的排尿恢复情况及不良反应。结果两组疗法均能有效改善患者的排尿状况,但临床组其改善程度显著于参照组,且不良反应显著低于参照组(P<0.05)。结论索利那新可更精确作用于泌尿系统,纠正逼尿肌发生的非自主性收缩。在显著改善患者综合排尿情况的同时,不良反应小,患者依从性强。
作者 王国桥
出处 《中国卫生产业》 2013年第20期76-76,78,共2页 China Health Industry
  • 相关文献

参考文献4

二级参考文献20

  • 1赵军,贺大林,刘润明,王明珠,王小宁,邢俊平,南勋义.良性前列腺增生相关的膀胱痉挛病因分析及治疗[J].中华男科学杂志,2005,11(4):275-277. 被引量:46
  • 2金锡禹,宋波主编.临床尿动力学[M].北京:人民卫生出版社,2002.165-166.
  • 3Athanasopoulos A,Gytopoulos K, Giannitsas K, et al. Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction : a prospective, randomized, controlled study[J]. J Urol, 2003,169(6) :2253-2256.
  • 4Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States [ J ] . World J Urol, 2003, 20(6) :327-336.
  • 5Bouchelouche K, Andersen L, Alvarez S, et al. Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction : effect of the alphalA and alphal D-adrenergic receptor antagonist tamsulosin[ J ] . J Urol, 2005, 173 (2) :657-661.
  • 6Masuda M, Nakayama K, Hiromoto Y, et al. Etiology of nocturia and clinical efficacy of naftopidil on nocturia in patients with benign prostatic hyperplasia-analysis of frequency volume charts [J]. Hinyokika Kiyo, 2004, 50(5) :309-314.
  • 7Nishino Y, Masue T, Miwa K, et al. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study[ J]. BJU Int, 2006, 97(4) :747-751.
  • 8Nickel JC, Narayan P, McKay J, et al. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial[J]. J Urol, 2004, 171 (4) : 1594- 1597.
  • 9Yamanishi T, Yasuda K, Kamai T, et al. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia [ J ]. Int J Urol, 2004, 11 (7) :501-509.
  • 10Debruyne F M, Heesakkers J P. Clinical and socioeconomic relevance of overactive bladder[J]. Urology, 2004, 63(3 Suppl 1 ) : 42 -44.

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部